Squamous cell carcinoma and Anaphylaxis

Summary:

Anaphylaxis is found among people with Squamous cell carcinoma, especially for people who are male, 60+ old.

The study analyzes which people have Anaphylaxis with Squamous cell carcinoma. It is created by eHealthMe based on reports of 40 people who have Squamous cell carcinoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Squamous cell carcinoma?

Squamous cell carcinoma (a cancer of a kind of epithelial cell) is found to be associated with 814 drugs and 895 conditions by eHealthMe. Check the latest studies of Squamous cell carcinoma.

What is Anaphylaxis?

Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death) is found to be associated with 1,942 drugs and 2,855 conditions by eHealthMe. Check the latest studies of Anaphylaxis.



On Jul, 10, 2026

40 people who have Squamous Cell Carcinoma and Anaphylaxis are studied.

Would you have Anaphylaxis when you have Squamous cell carcinoma?

Gender of people who have Squamous Cell Carcinoma and experienced Anaphylaxis *:

  • female: 37.84 %
  • male: 62.16 %

Age of people who have Squamous Cell Carcinoma and experienced Anaphylaxis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 10.81 %
  • 60+: 89.19 %

Common co-existing conditions for these people *:

  1. Pain: 2 people, 5.00%
  2. High Blood Pressure: 2 people, 5.00%
  3. Neoplasm Malignant (cancer tumour): 1 person, 2.50%
  4. Metastatic Squamous Cell Carcinoma (cancer of squamous cells spreads to other part): 1 person, 2.50%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 2.50%

Common drugs taken by these people *:

  1. Erbitux: 14 people, 35.00%
  2. Carboplatin: 8 people, 20.00%
  3. Benadryl: 4 people, 10.00%
  4. Paclitaxel: 4 people, 10.00%
  5. Polaramine: 3 people, 7.50%
  6. Decadron: 2 people, 5.00%
  7. Docetaxel: 2 people, 5.00%
  8. Esomeprazole Magnesium: 1 person, 2.50%
  9. Emend: 1 person, 2.50%
  10. Duragesic-100: 1 person, 2.50%

Common symptoms for these people *:

  1. Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 4 people, 10.00%
  2. Cardiac Arrest: 4 people, 10.00%
  3. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 3 people, 7.50%
  4. Hepatitis (inflammation of the liver): 3 people, 7.50%
  5. Infusion Related Reaction: 3 people, 7.50%
  6. Itching: 2 people, 5.00%
  7. Rashes (redness): 2 people, 5.00%
  8. Hypotension (abnormally low blood pressure): 2 people, 5.00%
  9. Bradycardia (abnormally slow heart action): 2 people, 5.00%
  10. Unresponsive To Stimuli: 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Anaphylaxis?

- Check whether Anaphylaxis is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Anaphylaxis:

All the conditions that are associated with Anaphylaxis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Anaphylaxis and Squamous cell carcinoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: